
### [NCIT:C4815](http://purl.obolibrary.org/obo/NCIT_C4815)
**Label:** Thyroid Gland Carcinoma

**Subclasses:** [NCIT:C46095](http://purl.obolibrary.org/obo/NCIT_C46095) (Solid Variant Thyroid Gland Papillary Carcinoma), [NCIT:C118829](http://purl.obolibrary.org/obo/NCIT_C118829) (Familial Nonmedullary Thyroid Gland Carcinoma), [NCIT:C46099](http://purl.obolibrary.org/obo/NCIT_C46099) (Hereditary Thyroid Gland Medullary Carcinoma), [NCIT:C46098](http://purl.obolibrary.org/obo/NCIT_C46098) (Sporadic Thyroid Gland Medullary Carcinoma), [NCIT:C7427](http://purl.obolibrary.org/obo/NCIT_C7427) (Thyroid Gland Diffuse Sclerosing Papillary Carcinoma), [NCIT:C6134](http://purl.obolibrary.org/obo/NCIT_C6134) (Stage II Thyroid Gland Medullary Carcinoma), [NCIT:C6133](http://purl.obolibrary.org/obo/NCIT_C6133) (Stage I Thyroid Gland Medullary Carcinoma), [NCIT:C6136](http://purl.obolibrary.org/obo/NCIT_C6136) (Stage IV Thyroid Gland Medullary Carcinoma), [NCIT:C4035](http://purl.obolibrary.org/obo/NCIT_C4035) (Thyroid Gland Papillary Carcinoma), [NCIT:C6135](http://purl.obolibrary.org/obo/NCIT_C6135) (Stage III Thyroid Gland Medullary Carcinoma), [NCIT:C9121](http://purl.obolibrary.org/obo/NCIT_C9121) (Stage III Thyroid Gland Follicular Carcinoma), [NCIT:C8054](http://purl.obolibrary.org/obo/NCIT_C8054) (Thyroid Gland Follicular Carcinoma), [NCIT:C9122](http://purl.obolibrary.org/obo/NCIT_C9122) (Stage III Thyroid Gland Papillary Carcinoma), [NCIT:C38762](http://purl.obolibrary.org/obo/NCIT_C38762) (Thyroid Gland Mucoepidermoid Carcinoma), [NCIT:C6040](http://purl.obolibrary.org/obo/NCIT_C6040) (Poorly Differentiated Thyroid Gland Carcinoma), [NCIT:C65200](http://purl.obolibrary.org/obo/NCIT_C65200) (Thyroid Gland Follicular Carcinoma, Minimally Invasive), [NCIT:C27380](http://purl.obolibrary.org/obo/NCIT_C27380) (Thyroid Gland Adenocarcinoma), [NCIT:C7906](http://purl.obolibrary.org/obo/NCIT_C7906) (Thyroid Gland Undifferentiated Carcinoma, Osteoclastic Variant), [NCIT:C35558](http://purl.obolibrary.org/obo/NCIT_C35558) (Tall Cell Variant Thyroid Gland Papillary Carcinoma), [NCIT:C7908](http://purl.obolibrary.org/obo/NCIT_C7908) (Recurrent Thyroid Gland Carcinoma), [NCIT:C118827](http://purl.obolibrary.org/obo/NCIT_C118827) (Childhood Thyroid Gland Carcinoma), [NCIT:C3878](http://purl.obolibrary.org/obo/NCIT_C3878) (Thyroid Gland Undifferentiated (Anaplastic) Carcinoma), [NCIT:C46004](http://purl.obolibrary.org/obo/NCIT_C46004) (Thyroid Gland Papillary Microcarcinoma), [NCIT:C123904](http://purl.obolibrary.org/obo/NCIT_C123904) (Childhood Thyroid Gland Follicular Carcinoma), [NCIT:C133193](http://purl.obolibrary.org/obo/NCIT_C133193) (Metastatic Thyroid Gland Carcinoma), [NCIT:C123905](http://purl.obolibrary.org/obo/NCIT_C123905) (Childhood Thyroid Gland Medullary Carcinoma), [NCIT:C46105](http://purl.obolibrary.org/obo/NCIT_C46105) (Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation), [NCIT:C46104](http://purl.obolibrary.org/obo/NCIT_C46104) (Thyroid Gland Mixed Medullary and Follicular Cell Carcinoma), [NCIT:C7153](http://purl.obolibrary.org/obo/NCIT_C7153) (Differentiated Thyroid Gland Carcinoma), [NCIT:C46008](http://purl.obolibrary.org/obo/NCIT_C46008) (Thyroid Gland Squamous Cell Carcinoma), [NCIT:C46106](http://purl.obolibrary.org/obo/NCIT_C46106) (Thyroid Gland Carcinoma Showing Thymus-Like Differentiation), [NCIT:C123903](http://purl.obolibrary.org/obo/NCIT_C123903) (Childhood Thyroid Gland Papillary Carcinoma), [NCIT:C9086](http://purl.obolibrary.org/obo/NCIT_C9086) (Stage IV Thyroid Gland Follicular Carcinoma), [NCIT:C9084](http://purl.obolibrary.org/obo/NCIT_C9084) (Stage I Thyroid Gland Follicular Carcinoma), [NCIT:C9085](http://purl.obolibrary.org/obo/NCIT_C9085) (Stage II Thyroid Gland Follicular Carcinoma), [NCIT:C87545](http://purl.obolibrary.org/obo/NCIT_C87545) (Stage III Differentiated Thyroid Gland Carcinoma), [NCIT:C9082](http://purl.obolibrary.org/obo/NCIT_C9082) (Stage II Thyroid Gland Papillary Carcinoma), [NCIT:C9083](http://purl.obolibrary.org/obo/NCIT_C9083) (Stage IV Thyroid Gland Papillary Carcinoma), [NCIT:C87543](http://purl.obolibrary.org/obo/NCIT_C87543) (Stage I Differentiated Thyroid Gland Carcinoma), [NCIT:C9081](http://purl.obolibrary.org/obo/NCIT_C9081) (Stage I Thyroid Gland Papillary Carcinoma), [NCIT:C87544](http://purl.obolibrary.org/obo/NCIT_C87544) (Stage II Differentiated Thyroid Gland Carcinoma), [NCIT:C3879](http://purl.obolibrary.org/obo/NCIT_C3879) (Thyroid Gland Medullary Carcinoma), [NCIT:C37304](http://purl.obolibrary.org/obo/NCIT_C37304) (Multicentric Thyroid Gland Papillary Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.89%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40399](http://purl.obolibrary.org/obo/NCIT_C40399) (Breast Leiomyoma))) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40398](http://purl.obolibrary.org/obo/NCIT_C40398) (Breast Inflammatory Myofibroblastic Tumor))) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40395](http://purl.obolibrary.org/obo/NCIT_C40395) (Malignant Breast Myoepithelioma))) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40388](http://purl.obolibrary.org/obo/NCIT_C40388) (Periductal Breast Myoepitheliosis))) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40384](http://purl.obolibrary.org/obo/NCIT_C40384) (Breast Ductal Adenoma))) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40383](http://purl.obolibrary.org/obo/NCIT_C40383) (Breast Apocrine Adenoma))) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40379](http://purl.obolibrary.org/obo/NCIT_C40379) (Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema))) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40378](http://purl.obolibrary.org/obo/NCIT_C40378) (Post-Radiotherapy Breast Angiosarcoma))) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40377](http://purl.obolibrary.org/obo/NCIT_C40377) (Breast Follicular Lymphoma))) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40376](http://purl.obolibrary.org/obo/NCIT_C40376) (Breast Burkitt Lymphoma))) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40375](http://purl.obolibrary.org/obo/NCIT_C40375) (Breast Diffuse Large B-Cell Lymphoma))) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome))) 39.20%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma))) 39.20%


